DAXOR (DXR) stock: insider trades, news & valuation
QuietShare price and insider trades
DAXOR insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 0 sold $0 of DXR stock on the open market.
Get emailed when insiders cluster-buy stocks like DXR
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
DXR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $9K | 1 | — | 0 |
| Q1 2026 | $10K | 1 | — | 0 |
Valuation, profit and volume
Summary
No open-market purchases or sales by DAXOR CORP insiders were reported in the past 12 months.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 10SEC | Michael Richard FeldschuhCEO | Buy | 1,000213,694 held (+0%) | $9.07 | $9K | +14.8% | — |
| Mar 31SEC | Robert J MichelCFO | Buy | 1,00021,050 held (+5%) | $9.90 | $10K | +5.2% | — |
| Mar 24SEC | John JefferiesChief Medical Officer | Buy | 3,65621,272 held (+21%) | — | $0 | — | — |
| Mar 24SEC | John JefferiesChief Medical Officer | Buy | 2,28523,557 held (+11%) | — | $0 | — | — |
| Dec 11SEC | Robert J MichelCFO | Buy | 3,00020,050 held (+18%) | — | $0 | — | — |
| Dec 11SEC | Jonathan Adam FeldschuhChief Scientific Officer | Buy | 18,00053,908 held (+50%) | — | $0 | — | — |
| Nov 14SEC | John JefferiesChief Medical Officer | Buy | 2,34417,616 held (+15%) | — | $0 | — | — |
Insiders at DAXOR CORP
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Robert J MichelCFO | $10K | — | Mar 31, 2026 | — |
| Michael Richard FeldschuhCEO | $9K | — | Apr 10, 2026 | — |
| John JefferiesChief Medical Officer | — | — | Mar 24, 2026 | — |
| Jonathan Adam FeldschuhChief Scientific Officer | — | — | Dec 11, 2025 | — |
DXR stock: common questions
Are DAXOR CORP insiders buying DXR stock?
In the past 12 months, 0 insiders reported open-market purchases of DXR worth $0. The latest was CEO Michael Richard Feldschuh bought $9K of DXR at $9.07 — first open-market purchase in our records.
Are DAXOR CORP insiders selling DXR stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is DXR's 52-week range?
Over the past year DXR has traded between $8.87 and $14.75. It last closed at $10.41 on Oct 9, 2026.